Orifarm reports progress on top line

Danish pharmaceutical firm Orifarm has reported a 27% increase in its revenue in one year.

Orifarm CEO Erik Sandberg | Photo: PR /Orifarm

Pharmaceutical firm Orifarm has reported that last year, its revenue increased by 27% compared to the preceding year, to total DKK 10.5bn (USD 1.5bn).

According to Danish financial daily Børsen, the pharmaceutical firm’s operating result increased by 39% on the preceding year to total DKK 413m (USD 58m) in 2021.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs